26 participants
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-24
- Start Date:
- 2007-01-31
- Completion:
- 2008-06-30
Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- Adult Lymphocyte Predominant Hodgkin Lymphoma
- Adult Mixed Cellularity Hodgkin Lymphoma
- Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Adult Nodular Sclerosis Hodgkin Lymphoma
- Childhood Lymphocyte Depletion Hodgkin Lymphoma
- Childhood Lymphocyte Predominant Hodgkin Lymphoma
- Childhood Mixed Cellularity Hodgkin Lymphoma
- Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Childhood Nodular Sclerosis Hodgkin Lymphoma
- Recurrent Adult Hodgkin Lymphoma
- Recurrent/Refractory Childhood Hodgkin Lymphoma
- Stage I Adult Hodgkin Lymphoma
- Stage I Childhood Hodgkin Lymphoma
- Stage II Adult Hodgkin Lymphoma
- Stage II Childhood Hodgkin Lymphoma
- Stage III Adult Hodgkin Lymphoma
- Stage III Childhood Hodgkin Lymphoma
- Stage IV Adult Hodgkin Lymphoma
- Stage IV Childhood Hodgkin Lymphoma
Interventions
- DRUG
- BIOLOGICAL